1. Amgen’s drug Parsabiv is intended to treat secondary hyperhythroidism in patients with chronic kidney disease who are undergoing dialysis.
2. The Seeker System is a screening test designed to detect four metabolic disorders in newborns.
3. Bristol-Myers Squibb’s best-selling cancer drug Opdivo can now be used to treat urothelial carcinoma — the most common type of bladder cancer.
4. Emflaza is intended to treat Duchenne’s muscular dystrophy, a rare degenerative condition that causes muscle weakness, loss of movement and eventually death.
More articles on supply chain:
Supply chain tip of the week: 9 questions to test your inventory management IQ
10 statistics on drug, device recalls in Q4
6 quotes from Pfizer CEO on Trump, drug prices and more
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
